HI SB868 | 2018 | Regular Session
Note: Carry Over of previous SB868
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2017 - 25% progression, died in committee
Action: 2017-11-30 - Carried over to 2018 Regular Session.
Pending: Senate Public Safety, Intergovernmental and Military Affairs Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 25 2017 - 25% progression, died in committee
Action: 2017-11-30 - Carried over to 2018 Regular Session.
Pending: Senate Public Safety, Intergovernmental and Military Affairs Committee
Text: Latest bill text (Amended) [HTML]
Summary
Amends Hawaii's controlled substances act to mirror federal regulations, which permit qualified practitioners to administer, dispense, and prescribe any schedule II, III, IV, or V narcotic drug approved by the Food and Drug Administration for use as a medically-managed withdrawal treatment, otherwise known as a detoxification treatment, or maintenance treatment; provided the practitioner complies with specific federal requirements. Allows physicians under certain circumstances to administer narcotic drugs to relieve acute withdrawal symptoms for not more than three days and to treat a person as an incidental adjunct to medical or surgical treatment. Effective 7/1/2050. (SD1)
Title
Relating To The Controlled Substances Act.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2017-11-30 | Carried over to 2018 Regular Session. | |
2017-02-16 | Senate | Report adopted; Passed Second Reading, as amended (SD 1) and referred to PSM. |
2017-02-16 | Senate | Reported from CPH (Stand. Com. Rep. No. 386) with recommendation of passage on Second Reading, as amended (SD 1) and referral to PSM. |
2017-02-14 | Senate | The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, Nishihara, S. Chang, Ihara, Kidani; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Espero, Ruderman. |
2017-02-08 | Senate | The committee(s) on CPH deferred the measure until 02-14-17 10:00AM in conference room 229. |
2017-02-02 | Senate | The committee(s) on CPH has scheduled a public hearing on 02-08-17 9:00AM in conference room 229. |
2017-01-30 | Senate | Re-Referred to CPH, PSM. |
2017-01-30 | Senate | The committee(s) on PSM deleted the measure from the public hearing scheduled on 01-31-17 1:15PM in conference room 229. |
2017-01-27 | Senate | The committee(s) on PSM has scheduled a public hearing on 01-31-17 1:15PM in conference room 229. |
2017-01-25 | Senate | Referred to PSM, CPH. |
2017-01-25 | Senate | Passed First Reading. |
2017-01-25 | Senate | Introduced. |
Same As/Similar To
HB1316 (Same As) 2018-01-17 - Re-referred to HHS, JUD, referral sheet 1
SB868 (Carry Over) 2017-02-16 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to PSM.
SB868 (Carry Over) 2017-02-16 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to PSM.
Subjects
Controlled Substances Act
Detoxification Treatment
Maintenance Treatment
Medically-managed Withdrawal Treatment
Prescriptions
Detoxification Treatment
Maintenance Treatment
Medically-managed Withdrawal Treatment
Prescriptions